Brief: Arovella Therapeutics Ltd Says Chile Ministry Of Health Approval Granted For Zolpimist
21/10/2021 02:10
Oct 21 (Reuters) - Arovella Therapeutics Ltd SUD.AX :
* CHILE MINISTRY OF HEALTH APPROVAL GRANTED FOR ZOLPIMIST
* MINISTRY OF HEALTH, CHILE, APPROVED REGISTRATION OF CO'S
PRODUCT
ZOLPIMIST TO TREAT SHORT-TERM INSOMNIA IN ADULTS
Source text for Eikon: ID:nASX194wB9
Further company coverage: SUD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO